[8-K] Regency Centers Corporation Reports Material Event
TriMas Corp. (TRS) Form 144 filing discloses a proposed sale of 63,965 common shares鈥攁bout 0.16 % of the 40.64 M shares outstanding鈥攙alued at roughly $2.24 M. The seller intends to execute the trade through Fidelity Brokerage Services on Nasdaq around 29 Jul 2025. All shares were acquired in 2021 via stock-option exercises and restricted-stock vesting; no prior sales were reported in the last three months. Form 144 is a notice, not an executed sale, but it signals potential insider liquidity activity. Given the small percentage of total shares, the transaction should have limited market impact unless accompanied by further disposals.
TriMas Corp. (TRS) deposito Form 144 rivela una proposta di vendita di 63.965 azioni ordinarie鈥攃irca lo 0,16% delle 40,64 milioni di azioni in circolazione鈥攙alutate approssimativamente 2,24 milioni di dollari. Il venditore intende eseguire la transazione tramite Fidelity Brokerage Services sul Nasdaq intorno al 29 luglio 2025. Tutte le azioni sono state acquisite nel 2021 tramite esercizio di opzioni su azioni e maturazione di azioni vincolate; non sono state segnalate vendite precedenti negli ultimi tre mesi. Il Form 144 猫 un avviso, non una vendita eseguita, ma indica una possibile attivit脿 di liquidit脿 da parte di insider. Considerata la piccola percentuale del totale azionario, la transazione dovrebbe avere un impatto limitato sul mercato a meno che non sia seguita da ulteriori cessioni.
TriMas Corp. (TRS) presentaci贸n del Formulario 144 revela una propuesta de venta de 63,965 acciones comunes鈥攁proximadamente el 0,16% de las 40,64 millones de acciones en circulaci贸n鈥攙aloradas en alrededor de 2,24 millones de d贸lares. El vendedor planea ejecutar la operaci贸n a trav茅s de Fidelity Brokerage Services en Nasdaq alrededor del 29 de julio de 2025. Todas las acciones fueron adquiridas en 2021 mediante el ejercicio de opciones sobre acciones y la consolidaci贸n de acciones restringidas; no se reportaron ventas previas en los 煤ltimos tres meses. El Formulario 144 es un aviso, no una venta ejecutada, pero indica una posible actividad de liquidez interna. Dado el peque帽o porcentaje del total de acciones, la transacci贸n deber铆a tener un impacto limitado en el mercado a menos que se acompa帽e de disposiciones adicionales.
TriMas Corp. (TRS) Form 144 鞝滌稖鞚� 鞎� 0.16%鞐� 頃措嫻頃橂姅 63,965欤� 氤错喌欤尖�旍礉 4,064毵� 欤� 欷戔�旊ゼ 鞎� 224毵� 雼煬鞐� 毵る弰頃� 鞓堨爼鞛勳潉 瓿店皽頃╇媹雼�. 韺愲Г鞛愲姅 2025雲� 7鞗� 29鞚�瓴� Nasdaq鞐愳劀 Fidelity Brokerage Services毳� 韱淀暣 瓯半灅毳� 鞁ろ枆頃� 瓿勴殟鞛呺媹雼�. 氇摖 欤检嫕鞚� 2021雲勳棎 鞀ろ啞鞓奠厴 頄夓偓 氚� 鞝滍暅 欤检嫕 甓岆Μ 頇曥爼鞙茧 旆摑頄堨溂氅�, 歆�雮� 3臧滌洈臧� 氤搓碃霅� 毵る弰 雮挫棴鞚� 鞐嗢姷雼堧嫟. Form 144電� 毵る弰 鞁ろ枆鞚� 鞎勲媽 韱奠靹滌澊歆�毵�, 雮措秬鞛� 鞙犽彊靹� 頇滊彊 臧�電レ劚鞚� 鞁滌偓頃╇媹雼�. 鞝勳泊 欤检嫕 欷� 牍勳鞚� 鞝侅柎 於旉皜 毵る弰 鞐嗢澊電� 鞁滌灔鞐� 氙胳箻電� 鞓來枼鞚� 鞝滍暅鞝�鞚� 瓴冹溂搿� 氤挫瀰雼堧嫟.
TriMas Corp. (TRS) d茅p么t du formulaire 144 r茅v猫le une proposition de vente de 63 965 actions ordinaires鈥攕oit environ 0,16 % des 40,64 millions d鈥檃ctions en circulation鈥攄鈥檜ne valeur d鈥檈nviron 2,24 millions de dollars. Le vendeur pr茅voit d鈥檈x茅cuter la transaction via Fidelity Brokerage Services sur le Nasdaq aux alentours du 29 juillet 2025. Toutes les actions ont 茅t茅 acquises en 2021 par l鈥檈xercice d鈥檕ptions d鈥檃chat d鈥檃ctions et la lev茅e de restrictions sur des actions restreintes ; aucune vente ant茅rieure n鈥檃 茅t茅 signal茅e au cours des trois derniers mois. Le formulaire 144 est un avis, non une vente r茅alis茅e, mais indique une possible activit茅 de liquidit茅 d鈥檌niti茅s. 脡tant donn茅 la faible proportion du total des actions, la transaction devrait avoir un impact limit茅 sur le march茅 sauf en cas de cessions suppl茅mentaires.
TriMas Corp. (TRS) Form 144 Meldung offenbart einen geplanten Verkauf von 63.965 Stammaktien鈥攅twa 0,16 % der 40,64 Millionen ausstehenden Aktien鈥攊m Wert von rund 2,24 Millionen US-Dollar. Der Verk盲ufer beabsichtigt, den Handel 眉ber Fidelity Brokerage Services an der Nasdaq um den 29. Juli 2025 durchzuf眉hren. Alle Aktien wurden 2021 durch Aus眉bung von Aktienoptionen und das Zuflie脽en von Restricted Stocks erworben; in den letzten drei Monaten wurden keine Verk盲ufe gemeldet. Das Form 144 ist eine Anzeige, kein ausgef眉hrter Verkauf, signalisiert jedoch potenzielle Insider-Liquidit盲tsaktivit盲ten. Aufgrund des geringen Anteils an den Gesamtaktien d眉rfte die Transaktion begrenzte Auswirkungen auf den Markt haben, sofern nicht weitere Verk盲ufe folgen.
- Sale equals only 0.16 % of shares outstanding, implying minimal dilution or supply pressure.
- No other insider sales reported in the prior 3 months, limiting aggregation concerns under Rule 144(e).
- Insider plans to liquidate $2.24 M of stock, which can be perceived as a confidence signal worth monitoring.
Insights
TL;DR: Modest insider sale (~0.16% of float); unlikely to move TRS shares materially.
Form 144 filings highlight insider intent rather than completed trades. Here, 63.9 k shares worth $2.24 M are slated for sale鈥攊nsignificant versus TriMas鈥� 40.6 M shares outstanding and typical daily volume. The stock was acquired through routine equity-comp programs in 2021, suggesting profit-taking rather than deterioration in fundamentals. Absence of other recent sales reduces aggregation risk under Rule 144(e). Overall, I view the filing as neutral; investors should monitor additional filings to gauge broader insider sentiment.
TriMas Corp. (TRS) deposito Form 144 rivela una proposta di vendita di 63.965 azioni ordinarie鈥攃irca lo 0,16% delle 40,64 milioni di azioni in circolazione鈥攙alutate approssimativamente 2,24 milioni di dollari. Il venditore intende eseguire la transazione tramite Fidelity Brokerage Services sul Nasdaq intorno al 29 luglio 2025. Tutte le azioni sono state acquisite nel 2021 tramite esercizio di opzioni su azioni e maturazione di azioni vincolate; non sono state segnalate vendite precedenti negli ultimi tre mesi. Il Form 144 猫 un avviso, non una vendita eseguita, ma indica una possibile attivit脿 di liquidit脿 da parte di insider. Considerata la piccola percentuale del totale azionario, la transazione dovrebbe avere un impatto limitato sul mercato a meno che non sia seguita da ulteriori cessioni.
TriMas Corp. (TRS) presentaci贸n del Formulario 144 revela una propuesta de venta de 63,965 acciones comunes鈥攁proximadamente el 0,16% de las 40,64 millones de acciones en circulaci贸n鈥攙aloradas en alrededor de 2,24 millones de d贸lares. El vendedor planea ejecutar la operaci贸n a trav茅s de Fidelity Brokerage Services en Nasdaq alrededor del 29 de julio de 2025. Todas las acciones fueron adquiridas en 2021 mediante el ejercicio de opciones sobre acciones y la consolidaci贸n de acciones restringidas; no se reportaron ventas previas en los 煤ltimos tres meses. El Formulario 144 es un aviso, no una venta ejecutada, pero indica una posible actividad de liquidez interna. Dado el peque帽o porcentaje del total de acciones, la transacci贸n deber铆a tener un impacto limitado en el mercado a menos que se acompa帽e de disposiciones adicionales.
TriMas Corp. (TRS) Form 144 鞝滌稖鞚� 鞎� 0.16%鞐� 頃措嫻頃橂姅 63,965欤� 氤错喌欤尖�旍礉 4,064毵� 欤� 欷戔�旊ゼ 鞎� 224毵� 雼煬鞐� 毵る弰頃� 鞓堨爼鞛勳潉 瓿店皽頃╇媹雼�. 韺愲Г鞛愲姅 2025雲� 7鞗� 29鞚�瓴� Nasdaq鞐愳劀 Fidelity Brokerage Services毳� 韱淀暣 瓯半灅毳� 鞁ろ枆頃� 瓿勴殟鞛呺媹雼�. 氇摖 欤检嫕鞚� 2021雲勳棎 鞀ろ啞鞓奠厴 頄夓偓 氚� 鞝滍暅 欤检嫕 甓岆Μ 頇曥爼鞙茧 旆摑頄堨溂氅�, 歆�雮� 3臧滌洈臧� 氤搓碃霅� 毵る弰 雮挫棴鞚� 鞐嗢姷雼堧嫟. Form 144電� 毵る弰 鞁ろ枆鞚� 鞎勲媽 韱奠靹滌澊歆�毵�, 雮措秬鞛� 鞙犽彊靹� 頇滊彊 臧�電レ劚鞚� 鞁滌偓頃╇媹雼�. 鞝勳泊 欤检嫕 欷� 牍勳鞚� 鞝侅柎 於旉皜 毵る弰 鞐嗢澊電� 鞁滌灔鞐� 氙胳箻電� 鞓來枼鞚� 鞝滍暅鞝�鞚� 瓴冹溂搿� 氤挫瀰雼堧嫟.
TriMas Corp. (TRS) d茅p么t du formulaire 144 r茅v猫le une proposition de vente de 63 965 actions ordinaires鈥攕oit environ 0,16 % des 40,64 millions d鈥檃ctions en circulation鈥攄鈥檜ne valeur d鈥檈nviron 2,24 millions de dollars. Le vendeur pr茅voit d鈥檈x茅cuter la transaction via Fidelity Brokerage Services sur le Nasdaq aux alentours du 29 juillet 2025. Toutes les actions ont 茅t茅 acquises en 2021 par l鈥檈xercice d鈥檕ptions d鈥檃chat d鈥檃ctions et la lev茅e de restrictions sur des actions restreintes ; aucune vente ant茅rieure n鈥檃 茅t茅 signal茅e au cours des trois derniers mois. Le formulaire 144 est un avis, non une vente r茅alis茅e, mais indique une possible activit茅 de liquidit茅 d鈥檌niti茅s. 脡tant donn茅 la faible proportion du total des actions, la transaction devrait avoir un impact limit茅 sur le march茅 sauf en cas de cessions suppl茅mentaires.
TriMas Corp. (TRS) Form 144 Meldung offenbart einen geplanten Verkauf von 63.965 Stammaktien鈥攅twa 0,16 % der 40,64 Millionen ausstehenden Aktien鈥攊m Wert von rund 2,24 Millionen US-Dollar. Der Verk盲ufer beabsichtigt, den Handel 眉ber Fidelity Brokerage Services an der Nasdaq um den 29. Juli 2025 durchzuf眉hren. Alle Aktien wurden 2021 durch Aus眉bung von Aktienoptionen und das Zuflie脽en von Restricted Stocks erworben; in den letzten drei Monaten wurden keine Verk盲ufe gemeldet. Das Form 144 ist eine Anzeige, kein ausgef眉hrter Verkauf, signalisiert jedoch potenzielle Insider-Liquidit盲tsaktivit盲ten. Aufgrund des geringen Anteils an den Gesamtaktien d眉rfte die Transaktion begrenzte Auswirkungen auf den Markt haben, sofern nicht weitere Verk盲ufe folgen.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|||
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Regency Centers Corporation
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|||
|
|
|||
|
|
Regency Centers, L.P.
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
None |
|
N/A |
|
N/A |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230 .425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02 |
Disclosure of Results of Operations and Financial Condition |
On July 29, 2025, Regency Centers Corporation ("Regency") issued an earnings release for the three and six months ended June 30, 2025, which is attached as Exhibit 99.1.
On July 29, 2025, Regency posted on its website, at investors.regencycenters.com, certain supplemental information for the three and six months ended June 30, 2025, which are attached as Exhibit 99.2 and Exhibit 99.3, respectively.
The information furnished under this Item 2.02, including Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act.
Item 7.01 |
Regulation FD Disclosures |
On July 29, 2025, Regency posted on its website, at investors.regencycenters.com, the Regency Centers Q2 2025 Earnings Presentation.
The information furnished under this item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act, or the Exchange Act.
Item 9.01 |
Financial Statements and Exhibits |
(d) Exhibits
Exhibit 99.1 |
Earnings release issued by Regency on July 29, 2025, for the three and six months ended June 30, 2025. |
|
|
Exhibit 99.2 |
Supplemental information posted on its website on July 29, 2025, for the three and six months ended June 30, 2025. |
|
|
Exhibit 99.3 |
Fixed income supplemental information posted on its website on July 29, 2025, for the three and six months ended June 30, 2025. |
104 |
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL documents) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
REGENCY CENTERS CORPORATION |
||
|
|
|
|
|
July 29, 2025 |
|
By: |
|
/s/ Michael R. Herman |
|
|
|
|
Michael R. Herman, Senior Vice President General Counsel and Corporate Secretary |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REGENCY CENTERS, L.P. |
||
|
|
|
|
|
|
|
By: Regency Centers Corporation, its general partner |
||
|
|
|
|
|
July 29, 2025 |
|
By: |
|
/s/ Michael R. Herman |
|
|
|
|
Michael R. Herman, Senior Vice President General Counsel and Corporate Secretary |
Source:
FAQ
How many TriMas (TRS) shares are being registered for sale?
What is the market value of the proposed TRS share sale?
When is the planned sale date for the TRS shares?
How large is the sale relative to TriMas鈥� shares outstanding?
What exchange will the TRS shares be sold on?
